Finance

Beta
Lists
VTVT:NASDAQ
vTv Therapeutics Inc
$33.54
+2.37%
(+0.78) 1D
Jun 15, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for VTVT...
Open
$33.46
High
$33.75
Low
$32.13
Mkt. cap
132.09M
Avg. vol.
38.89K
Volume
52.21K
52-wk high
$44.00
52-wk low
$14.00
EPS
-$0.92
Beta
0.29
Shares outstanding
3.94M
No. of employees
26
Open
$33.46
High
$33.75
Low
$32.13
Mkt. cap
132.09M
Avg. vol.
38.89K
Volume
52.21K
52-wk high
$44.00
52-wk low
$14.00
EPS
-$0.92
Beta
0.29
Shares outstanding
3.94M
No. of employees
26
Analyst outlook
Analyst Ratings
Based on 5 analysts giving stock ratings to VTVT in the past 3 months
Strong Buy
Buy
5
Hold
0
Sell
0
12 month forecast
Based on 5 Wall Street analysts offering 12 month price targets for VTVT in the last 3 months.
Highest
Current $33.54
$67.00 (+99.76%)
Average
$54.80 (+63.39%)
Lowest
$45.00 (+34.17%)
News stories
From sources across the web
About vTv Therapeutics Inc
CEO-
Employees26
Founded2015
HeadquartersHigh Point, North Carolina, United States
SectorBiotechnology
Websitevtvtherapeutics.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
36.84M
Cost of goods sold
4.10M
7.02M
3.91M
8.98M
Cost of revenue
4.10M
7.02M
3.91M
8.98M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
3.62M
3.68M
3.98M
4.60M
Operating expense
3.62M
3.68M
3.98M
4.60M
Total operating expenses
7.72M
10.70M
7.88M
13.58M
Operating income
-7.72M
-10.70M
-7.88M
23.26M
Other non operating income
66.00K
-40.00K
-117.00K
33.00K
EBT including unusual items
-7.38M
-10.34M
-7.14M
24.13M
EBT excluding unusual items
-7.38M
-10.34M
-7.14M
24.13M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-6.05M
-8.70M
-7.14M
24.13M
Net profit margin
-
-
-
65.51%
Earnings per share
-0.92
-1.08
-0.58
1.65
Interest and investment income
275.00K
399.00K
865.00K
838.00K
Interest expense
-
-5.00K
-1.00K
-
Net interest expenses
275.00K
394.00K
864.00K
838.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-7.72M
-10.70M
-7.88M
23.26M
Gain or loss from assets sale
-
-
6.00K
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer